Investor Relations
Transforming the $150B+ data sharing opportunity through AI-powered federated marketplaces
Business Model
Unique Market Position
The only patient-centric, cross-sector data sharing platform with transaction-aligned pricing. Unlike competitors focused on single verticals, we serve patients, researchers, and companies across healthcare and data-driven technology companies (e.g. AI)
Critical Bottlenecks Solution
Addressing the $100B+ opportunity in accelerated drug discovery, and $50B+ in precision medicine by enabling access to AI-ready, diverse datasets that are currently siloed.
Scalable Business Model
Multi-revenue stream approach: subscription tiers ($500-$15K/month), transaction fees (1-5%), and marketplace commissions. Platform designed for rapid cross-sector expansion beyond initial healthcare focus.
Target Customers
Business Leaders & Healthcare System CIOs
Who are concerned about their data costs and if they can get return investment on their existing data
Clinicians
Who want to experiment with AI and want to see results published
Data Owners
Who want to share data with the purpose of capitalizing on their initial investment
Researchers
Who want to sell their app to hospitals and is able to use marketplace data to validate their algorithm more robustly
Biotech R&D Leads
Who have more data availability to use in models and is able to capitalize on their existing data without compromising security
Sector-Specific Critical Data Bottlenecks
Biopharma & Life Sciences
Antibody/Antigen Research
AI models for next-gen vaccines and therapeutics lack large, diverse immunological datasets (paired BCR repertoire + structural/functional outcomes)
Rare Disease Development
Extremely valuable orphan markets limited by tiny patient cohorts and fragmented clinical data
Clinical Trial Optimization
Trial data remains siloed, proprietary, and unstructured, limiting predictive modeling. Pharma partners are willing to share for specific purposes but need technology beyond
Healthcare Diagnostics
Digital Pathology
Gigapixel pathology datasets lack scale, annotation consistency, and global representation (especially low/middle-income populations)
Multimodal Patient Records
Transformative potential locked in incompatible hospital EHRs with privacy constraints
Agriculture & Food Systems
Plant Disease Detection
Few standardized, global plant pathology databases across climates and crop types
Microbiome Research
Gut microbiome datasets for personalized nutrition remain small, biased, and noisy
Investment Opportunity
Join us in revolutionizing the $150B+ data sharing market. Our unique position at the intersection of AI, healthcare, and data compliance creates unprecedented opportunities for growth and impact.